Remodeling of calcium entry pathways in cancer

Advances in Experimental Medicine and Biology

Volumn 898, Issue , 2016, Pages 449-466

  Villalobos, Carlos ^a   Sobradillo, Diego ^a   Hernández Morales, Miriam ^a   Núñez, Lucía ^a  

^a University of Valladolid   (Spain)

Author keywords

Aspirin; Cancer; Colorectal cancer; NSAID; Store operated Ca2+ entry

Indexed keywords

MEMBRANE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN ORAI3; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; STROMAL INTERACTION MOLECULE 1; STROMAL INTERACTION MOLECULE 2; TRANSCRIPTION FACTOR NFAT; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 4; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; TRANSIENT RECEPTOR POTENTIAL CHANNEL 7; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 4; VANILLOID RECEPTOR 6; VOLTAGE GATED CALCIUM CHANNEL; ACETYLSALICYLIC ACID; CALCIUM;

BINDING SITE; BREAST CANCER; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CANCER PREVENTION; CELL PROLIFERATION; COLON CARCINOGENESIS; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; HUMAN; MEMBRANE DEPOLARIZATION; MITOCHONDRION; MOLECULAR DYNAMICS; NEOPLASM; NONHUMAN; OLIGOMERIZATION; PLANAR PATCH CLAMP; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; STORE INDEPENDENT CALCIUM ENTRY; STORE OPERATED CALCIUM ENTRY; ANIMAL; HOMEOSTASIS; ION TRANSPORT; METABOLISM; NEOPLASMS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CALCIUM; HOMEOSTASIS; HUMANS; ION TRANSPORT; NEOPLASMS;

EID: 84986258334     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-26974-0_19     Document Type: Chapter

References (77)

1. Baughman JM, Perocchi F, Girgis HS, Plovanich M, Belcher-Timme CA, Sancak Y, Bao XR, Strittmatter L, Goldberger O, Bogorad RL, Koteliansky V, Mootha VK (2011) Integrative genomics identifi es MCU as an essential component of the mitochondrial calcium uniporter. Nature 476:341–345.
2. De Stefani D, Raffaello A, Teardo E, Szabò I, Rizzuto R (2011) A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 476:336–340.
3. 2+ transients that modulate secretion. Nat Cell Biol 2(2):57–61.
4. 2+ among cytosol and organella during stimulation of bovine chromaffin cells. FASEB J 16(3):343–353.
5. Quintana A, Pasche M, Junker C, Al-Ansary D, Rieger H, Kummerow C, Nuñez L, Villalobos C, Meraner P, Becherer U, Rettig J, Niemeyer BA, Hoth M (2011) Calcium microdomains at the immunological synapse: how ORAI channels, mitochondria and calcium pumps generate local calcium signals for efficient T-cell activation. EMBO J 30:3895–3912.
6. 2+ ] in the endoplasmic reticulum with aequorin. Cell Calcium 32(5–6):251–260.
7. Hewavitharana T, Deng X, Soboloff J, Gill DL (2007) Role of STIM and Orai proteins in the store-operated calcium signaling pathway. Cell Calcium 42:173–182.
8. Putney JW (2009) Capacitative calcium entry: from concept to molecules. Immunol Rev 231:10–22.
9. 2+ (CRAC) current, structure, and function. Cell Mol Life Sci 69:4163–4176.
10. 2+ levels. Cell 131:1327–1339.
11. Hoth M, Niemeyer BA (2013) The neglected CRAC proteins: Orai2, Orai3, and STIM2. Curr Top Membr 1:237–271.
12. Ma X, Nilius B, Wong JW, Huang Y, Yao X (2011) Electrophysiological properties of heteromeric TRPV4-C1 channels. Biochim Biophys Acta 1808:2789–2797.
13. 2+ entry. Curr Top Membr 71:149–179.
14. Monteith GR, Davis FM, Roberts-Thomson SJ (2012) Calcium channels and pumps in cancer: changes and consequences. J Biol Chem 287:31666–31673.
15. Prevarskaya N, Ouadid-Ahidouch H, Skryma R, Shuba Y (2014) Remodelling of Ca 2+ transport in cancer: how it contributes to cancer hallmarks? Philos Trans R Soc Lond B Biol Sci 369:20130097.
16. Prevarskaya N, Skryma R, Shuba Y (2011) Calcium in tumor metastasis: new roles for known actors. Nat Rev Cancer 11:609–618.
17. 2+ entry through STIM and ORAI proteins in immunity, hemostasis and cancer. Channels 7:379–391.
18. Stewart TA, Yapa KT, Monteith GR (2015) Altered calcium signaling in cancer cells. Biochim Biophys Acta 1848 (10):2502–11.
19. 2+ for cell proliferation and survival. Nat Cancer Rev 8:361–375.
20. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, Kinzler KW (1997) Gene expression profi les in normal and cancer cells. Science 276:1268–1272.
21. Wang JY, Sun J, Huang MY, Wang YS, Hou MF, Sun Y, He H, Krishna N, Chiu SJ, Lin S, Yang S, Chang WC. STIM1 overexpression promotes colorectal cancer progression, cell motility and COX-2 expression. Oncogene Nov 10. Wang XT, Nagaba Y, Cross HS, Wrba F, Zhang L, Guggino SE (2000) The mRNA of L-type calcium channel elevated in colon cancer: protein distribution in normal and cancerous colon. Am J Pathol 157:1549–1562.
22. Toyota M, Ho C, Ohe-Toyota M, Baylin SB, Issa JP (1999) Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5′ CpG island in human tumors. Cancer Res 59:4535–4541.
23. Gackiere F, Bidaux G, Delcourt P, Van Coppenolle F, Katsogiannou M, Dewailly E, Bavencoffe A, Van Chuoi-Mariot MT, Mauroy B, Prevarskaya N, Mariot P (2008) Cav 3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells. J Biol Chem 283:10162–10173.
24. Taylor JT, Zeng XB, Pottle JE, Lee K, Wang AR, Yi SG, Scruggs JA, Sikka SS, Li M (2008) Calcium signaling and T-type calcium channels in cancer cell cycling. World J Gastroenterol 14:4984–4991.
25. 2+ entry into GH 3 and chromaffin cells by imidazole antimycotics and other cytochrome P 450 blockers. FASEB J 6(9):2742–2747.
26. Dhennin-Duthille I, Gautier M, Faouzi M, Guilbert A, Brevet M, Vaudry D, Ahidouch A, Sevestre H, Ouadid-Ahidouch H (2011) High expression of transient receptor potential channels in human breast cancer epithelial cells and tissues: correlation with pathological parameters. Cell Physiol Biochem 28:813–822.
27. Yang S, Zhang JJ, Huang XY (2009) Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 5:124–134.
28. Aydar E, Yeo S, Djamgoz M, Palmer C (2009) Abnormal expression, localization and interaction of canonical transient receptor potential ion channels in human breast cancer cell lines and tissues: a potential target for breast cancer diagnosis and therapy. Cancer Cell Int 9:23.
29. Veliceasa D, Ivanovic M, Hoepfner FT, Thumbikat P, Volpert OV, Smith ND (2007) Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma. FEBS J 274:6365–6377.
30. Shi Y, Ding X, He ZH, Zhou KC, Wang Q, Wang YZ (2009) Critical role of TRPC6 channels in G2 phase transition and the development of human oesophageal cancer. Gut 58:1443–1450.
31. Zhang SS, Wen J, Yang F, Cai XL, Yang H, Luo KJ, Liu QW, Hu RG, Xie X, Huang QY, Chen JY, Fu JH, Hu Y (2013) High expression of transient potential receptor C6 correlated with poor prognosis in patients with esophageal squamous cell carcinoma. Med Oncol 30:607.
32. Cai R, Ding X, Zhou K, Shi Y, Ge R, Ren G, Jin Y, Wang Y (2009) Blockade of TRPC6 channels induced G2/M phase arrest and suppressed growth in human gastric cancer cells. Int J Cancer 125:2281–2287.
33. Ding X, He Z, Zhou K, Cheng J, Yao H, Lu D, Cai R, Jin Y, Dong B, Xu Y, Wang Y (2010) Essential role of TRPC6 channels in G2/M phase transition and development of human glioma. J Natl Cancer Inst 102:1052–1068.
34. El Boustany C, Bidaux G, Enfi ssi A, Delcourt P, Prevarskaya N, Capiod T (2008) Capacitative calcium entry and transient receptor potential canonical 6 expression control human hepatoma cell proliferation. Hepatology 47:2068–2077.
35. Guilbert A, Dhennin-Duthille I, Hiani YE, Haren N, Khorsi H, Sevestre H, Ahidouch A, Ouadid-Ahidouch H (2008) Expression of TRPC6 channels in human epithelial breast cancer cells. BMC Cancer 8:125.
36. Wang JY, Sun J, Huang MY, Wang YS, Hou MF, Sun Y, He H, Krishna N, Chiu SJ, Lin S, Yang S, Chang WC (2015) STIM1 overexpression promotes colorectal cancer progression, cell motility and COX-2 expression. Oncogene 34(33):4358–4367.
37. Zhuang L, Peng JB, Tou L, Takanaga H, Adam RM, Hediger MA, Freeman MR (2002) Calcium-selective ion channel, CaT1, is apically localized in gastrointestinal tract epithelia and is aberrantly expressed in human malignancies. Lab Invest 82:1755–1764.
38. Capiod T, Shuba Y, Skryma R, Prevarskaya N (2007) Calcium signaling and cancer cell growth. Subcell Biochem 45:405–427.
39. Raphaël M, Lehen’kyi V, Vandenberghe M, Beck B, Khalimonchyk S, Vanden Abeele F, Farsetti L, Germain E, Bokhobza A, Mihalache A, Gosset P, Romanin C, Clézardin P, Skryma R, Prevarskaya N (2014) TRPV6 calcium channel translocates to the plasma membrane via Orai1-mediated mechanism and controls cancer cell survival. Proc Natl Acad Sci U S A 111(37):E3870–E3879.
40. Déliot N, Constantin B (2015) Plasma membrane calcium channels in cancer: alterations and consequences for cell proliferation and migration. Biochim Biophys Acta 1848:2512–2522.
41. Fusi C, Materazzi S, Minocci D, Maio V, Oranges T, Massi D, Nassini R (2014) Transient receptor potential vanilloid 4 (TRPV4) is downregulated in keratinocytes in human nonmelanoma skin cancer. J Invest Dermatol 134:2408–2417.
42. Mizuno H, Suzuki Y, Watanabe M, Sokabe T, Yamamoto T, Hattori R, Gotoh M, Tominaga M (2014) Potential role of transient receptor potential (TRP) channels in bladder cancer cells. J Physiol Sci 64(4):305–314.
43. Bolanz KA, Hediger MA, Landowski CP (2008) The role of TRPV6 in breast carcinogenesis. Mol Cancer Ther 7:271–279.
44. Peng JB, Zhuang L, Berger UV, Adam RM, Williams BJ, Brown EM, Hediger MA, Freeman MR (2001) CaT1 expression correlates with tumor grade in prostate cancer. Biochem Biophys Res Commun 282:729–734.
45. Wissenbach U, Niemeyer BA, Fixemer T, Schneidewind A, Trost C, Cavalie A, Reus K, Meese E, Bonkhoff H, Flockerzi V (2001) Expression of CaT-like, a novel calcium-selective channel, correlates with the malignancy of prostate cancer. J Biol Chem 276(22):19461–19468.
46. Fan H, Shen YX, Yuan YF (2014) Expression and prognostic roles of TRPV5 and TRPV6 in non-small cell lung cancer after curative resection. Asian Pac J Cancer Prev 15:2559–2563.
47. Yee NS, Zhou W, Lee M (2010) Transient receptor potential channel TRPM8 is over-expressed and required for cellular proliferation in pancreatic adenocarcinoma. Cancer Lett 297:49–55.
48. Tsavaler L, Shapero MH, Morkowski S, Laus R (2001) Trp-p8, a novel prostate-specifi c gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Res 61:3760–3769.
49. Fuessel S, Sickert D, Meye A, Klenk U, Schmidt U, Schmitz M, Rost AK, Weigle B, Kiessling A, Wirth MP (2003) Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR. Int J Oncol 23:221–228.
50. Schmidt U, Fuessel S, Koch R, Baretton GB, Lohse A, Tomasetti S, Unversucht S, Froehner M, Wirth MP, Meye A (2006) Quantitative multi-gene expression profi ling of primary prostate cancer. Prostate 66(14):1521–1534.
51. Prevarskaya N, Flourakis M, Bidaux G, Thebault S, Skryma R (2007) Differential role of TRP channels in prostate cancer. Biochem Soc Trans 35(1):133–135.
52. Chodon D, Guilbert A, Dhennin-Duthille I, Gautier M, Telliez MS, Sevestre H, Ouadid- Ahidouch H (2010) Estrogen regulation of TRPM8 expression in breast cancer cells. BMC Cancer 10:212.
53. Liu J, Chen Y, Shuai S, Ding D, Li R, Luo R (2014) TRPM8 promotes aggressiveness of breast cancer cells by regulating EMT via activating AKT/GSK-3β pathway. Tumour Biol 35(9):8969–8977.
54. Chen YF, Chiu WT, Chen YT, Lin PY, Huang HJ, Chou CY, Chang HC, Tang MJ, Shen MR (2011) Calcium store sensor stromal-interaction molecule1-dependent signaling plays an important role in cervical cancer growth, migration and angiogenesis. Proc Natl Acad Sci U S A 108:15225–15230.
55. Li G, Zhang Z, Wang R, Ma W, Yang Y, Wei J, Wei Y (2013) Suppression of STIM1 inhibits human glioblastoma cell proliferation and induces G0/G1 phase arrest. J Exp Clin Cancer Res 32:20.
56. Motiani RK, Hyzinski-García MC, Zhang X, Henkel MM, Abdullaev IF, Kuo YH, Matrougui K, Mongin AA, Trebak M (2013) STIM1 and Orai1 mediate CRAC channel activity and are essential for human glioblastoma invasion. Pflugers Arch 465(9):1249–1260.
57. McAndrew D, Grice DM, Peters AA, Davis FM, Stewart T, Rice M, Smart CE, Brown MA, Kenny PA, Roberts-Thomson SJ, Monteith GR (2011) ORAI1-mediated calcium infl ux in lactation and in breast cancer. Mol Cancer Ther 10:448–460.
58. 2+ channel that promotes tumorigenesis. FASEB J 27(1):63–75.
59. Ay AS, Benzerdjeb N, Sevestre H, Ahidouch A, Ouadid-Ahidouch H (2013) Orai3 constitutes a native store-operated calcium entry that regulates non small cell lung adenocarcinoma cell proliferation. PLoS One 8(9):e72889.
60. Zhu M, Chen L, Zhao P, Zhou H, Zhang C, Yu S, Lin Y, Yang X (2014) Store-operated Ca 2+ entry regulates glioma cell migration and invasion via modulation of Pyk2 phosphorylation. J Exp Clin Cancer Res 33:98.
61. 2+ entry (SOCE) regulates melanoma proliferation and cell migration. PLoS One 9:e89292.
62. Kim JH, Lkhagvadorj S, Lee MR, Hwang KH, Chung HC, Jung JH, Cha SK, Eom M (2014) Orai1 and STIM1 are critical for cell migration and proliferation of clear cell renal cell carcinoma. Biochem Biophys Res Commun 448:76–82.
63. Faouzi M, Hague F, Potier M, Ahidouch A, Sevestre H, Ouadid-Ahidouch H (2011) Downregulation of Orai3 arrests cell-cycle progression and induces apoptosis in breast cancer cells but not in normal breast epithelial cells. J Cell Physiol 226:542–551.
64. CRAC controls the rapid androgen response in human primary prostate epithelial cells and is altered in prostate cancer. Oncotarget 4:2096–2107.
65. Dubois C, Vanden Abeele F, Lehen’kyi V, Gkika D, Guarmit B, Lepage G, Slomianny C, Borowiec AS, Bidaux G, Benahmed M, Shuba Y, Prevarskaya N (2014) Remodeling of channel- forming ORAI proteins determines an oncogenic switch in prostate cancer. Cancer Cell 26:19–32.
66. Scrideli CA, Carlotti CG Jr, Okamoto OK, Andrade VS, Cortez MA, Motta FJ, Lucio-Eterovic AK, Neder L, Rosemberg S, Oba-Shinjo SM, Marie SK, Tone LG (2008) Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identifi cation of potential target genes by oligonucleotide microarray and real-time quantitative PCR. J Neurooncol 88:281–291.
67. Ruano Y, Mollejo M, Ribalta T, Fiano C, Camacho FI, Gomez E, de Lope AR, Hernandez- Moneo JL, Martinez P, Melendez B (2006) Identifi cation of novel candidate target genes in amplicons of glioblastoma multiforme tumors detected by expression and CGH microarray profi ling. Mol Cancer 5:39.
68. Aytes A, Mollevi DG, Martinez-Iniesta M, Nadal M, Vidal A, Morales A, Salazar R, Capella G, Villanueva A (2012) Stromal interaction molecule 2 (STIM2) is frequently overexpressed in colorectal tumors and confers a tumor cell growth suppressor phenotype. Mol Carcinog 51:746–753.
69. 2+ remodeling and cancer hallmarks in colorectal carcinoma cells. J Biol Chem 289:28765–28782.
70. 2+ uptake: inhibition by salicylate. J Physiol (Lond) 571:57–73.
71. Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW (2011) Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomized trials. Lancet 377:31–41.
72. Arber N, Levin B (2008) Chemoprevention of colorectal neoplasia: the potential for personalized medicine. Gastroenterology 134(4):1224–1237.
73. Burn J, Mathers JC, Bishop DT (2013) Chemoprevention in Lynch syndrome. Fam Cancer 12(4):707–718.
74. Weiss H, Amberger A, Widschwendter M, Margreiter R, Ofner D, Dietl P (2001) Inhibition of store-operated calcium entry contributes to the anti-proliferative effect of non-steroidal antiinfl ammatory drugs in human colon cancer cells. Int J Cancer 92(6):877–882.
75. Valero RA, Senovilla L, Núñez L, Villalobos C (2008) The role of mitochondrial potential in control of calcium signals involved in cell proliferation. Cell Calcium 44:259–269.
76. 2+ - dependent inactivation of calcium release-activated calcium/Orai channels normally prevented by mitochondria. J Biol Chem 286:16186–16196.
77. 2+ remodeling during the phenotypic journey of human coronary smooth muscle cells. Cell Calcium 54:375–385